Hasan, T., Medcalf, E., Nyang'wa, B., Egizi, E., Berry, C., Dodd, M., . . . Fox, G. (2024). The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis. Clinical infectious diseases, 78(3), 730-741. https://doi.org/10.1093/cid/ciad653
Citace podle Chicago (17th ed.)Hasan, Tasnim, et al. "The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis." Clinical Infectious Diseases 78, no. 3 (2024): 730-741. https://doi.org/10.1093/cid/ciad653.
Citace podle MLA (9th ed.)Hasan, Tasnim, et al. "The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis." Clinical Infectious Diseases, vol. 78, no. 3, 2024, pp. 730-741, https://doi.org/10.1093/cid/ciad653.